1.0Avalere Health Advisoryhttps://advisory.avalerehealth.comImpact of J-Code Naming Conventions on 505(b)(2) Drugs | Avalere Health Advisoryrich600338<blockquote class="wp-embedded-content" data-secret="oaQ9yM2G0X"><a href="https://advisory.avalerehealth.com/insights/impact-of-j-code-naming-conventions-on-505b2-drugs">Impact of J-Code Naming Conventions on 505(b)(2) Drugs</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/insights/impact-of-j-code-naming-conventions-on-505b2-drugs/embed#?secret=oaQ9yM2G0X" width="600" height="338" title="“Impact of J-Code Naming Conventions on 505(b)(2) Drugs” — Avalere Health Advisory" data-secret="oaQ9yM2G0X" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
https://advisory.avalerehealth.com/wp-content/uploads/2022/07/21027-1-Becky_Snow-400x600-1.jpg600400Since 2022, the Centers for Medicare and Medicaid Services (CMS) has been reviewing its approach for establishing Healthcare Common Procedure Coding System (HCPCS) Level II codes for products approved under the 505(b)(2) pathway. According to CMS’s current practice, products approved under separate 505(b)(2) New Drug Applications that are not rated as therapeutically equivalent in the…